Open-label study to assess the safety and tolerability of ADV7103 as compared to Standard of Care after a 2-year treatment period, in children from 6 months to less than 18 years of age with cystinuria (and in adults).
Phase of Trial: Phase II
Latest Information Update: 28 Oct 2015
At a glance
- Drugs Potassium bicarbonate/potassium citrate (Primary)
- Indications Cystinuria
- Focus Adverse reactions
- 28 Oct 2015 New trial record